DIFFERENT CONTEXTS, DIFFERENT PAINS, DIFFERENT EXPERIENCES

被引:58
作者
Carlino, E. [1 ]
Benedetti, F. [1 ,2 ,3 ]
机构
[1] Univ Turin, Sch Med, Neurosci Dept, Turin, Italy
[2] Plateau Rosa Labs, Breuil Cervinia, Italy
[3] Plateau Rosa Labs, Zermatt, Switzerland
关键词
context; placebo; nocebo; reward; analgesia; CHOLECYSTOKININ ANTAGONIST PROGLUMIDE; PLACEBO ANALGESIA; INDIVIDUAL-DIFFERENCES; NOCEBO HYPERALGESIA; BRAIN ACTIVITY; NEURAL MECHANISMS; OPIOID ACTIVITY; SPINAL-CORD; RESPONSES; ANTICIPATION;
D O I
10.1016/j.neuroscience.2016.01.053
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pain is an ambiguous perception: the same pain stimulation can be perceived differently in different contexts, producing different experiences, ranging from mild to unbearable pain. It can be even experienced as a rewarding sensation within the appropriate context. Overall, placebo and nocebo effects appear to be very good models to understand how the psychosocial context modulates the experience of pain. In this review, we examine the effects of different contexts on pain, with a specific focus on the neurobiological mechanisms. Positive and rewarding contexts inform the patients that an effective treatment is being delivered and are capable of producing pain relief through the activation of specific systems such as opioids, cannabinoids and dopamine. Conversely, a negative context can produce pain exacerbation and clinical worsening through the modulation of different systems, such as the activation of cholecystokinin and the deactivation of opioids and dopamine. In addition, when a therapy is delivered unbeknownst to the patient, its effects are reduced. A better understanding of the neurobiological underpinnings of the context-pain interaction is a challenge both for future pain research and for good clinical practice. This article is part of a Special Issue entitled: Pain. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 108 条
[1]   Response variability to analgesics: a role for non-specific activation of endogenous opioids [J].
Amanzio, M ;
Pollo, A ;
Maggi, G ;
Benedetti, F .
PAIN, 2001, 90 (03) :205-215
[2]   Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems [J].
Amanzio, M ;
Benedetti, F .
JOURNAL OF NEUROSCIENCE, 1999, 19 (01) :484-494
[3]   A systematic review of adverse events in placebo groups of anti-migraine clinical trials [J].
Amanzio, Martina ;
Corazzini, Luca Latini ;
Vase, Lene ;
Benedetti, Fabrizio .
PAIN, 2009, 146 (03) :261-269
[4]  
[Anonymous], PREVENT TREAT
[5]   Medicine's inconvenient truth: the placebo and nocebo effect [J].
Arnold, M. H. ;
Finniss, D. G. ;
Kerridge, I. .
INTERNAL MEDICINE JOURNAL, 2014, 44 (04) :398-405
[6]   Opposite effects of the same drug: reversal of topical analgesia by nocebo information [J].
Aslaksen, Per Matti ;
Zwarg, Maria Lorentze ;
Eilertsen, Hans-Ingvald Hage ;
Gorecka, Marta Maria ;
Bjorkedal, Espen .
PAIN, 2015, 156 (01) :39-46
[7]   Dissociable Influences of Opiates and Expectations on Pain [J].
Atlas, Lauren Y. ;
Whittington, Robert A. ;
Lindquist, Martin A. ;
Wielgosz, Joe ;
Sonty, Nomita ;
Wager, Tor D. .
JOURNAL OF NEUROSCIENCE, 2012, 32 (23) :8053-8064
[8]  
BALINT M, 1955, LANCET, V1, P683
[9]   When words are painful: Unraveling the mechanisms of the nocebo effect [J].
Benedetti, F. ;
Lanotte, M. ;
Lopiano, L. ;
Colloca, L. .
NEUROSCIENCE, 2007, 147 (02) :260-271
[10]   Hidden Administration of Drugs [J].
Benedetti, F. ;
Carlino, E. ;
Pollo, A. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (05) :651-661